Barlicki University Hospital / Medical University of Lodz / / /
IndustryTerm
health insurance / /
MedicalCondition
near-fatal asthma / allergic diseases / achieved asthma / disease / severe persistent asthma / moderate-to-severe allergic asthma / chronic treatment / Mean asthma / severe persistent uncontrolled allergic asthma / anaphylaxis / severe asthma Nearfatal asthma OMA / allergy / Kuna P. Epidemics / severe bronchial asthma / Insect Venom Hypersensitivity / treatment-resistant severe asthma / good asthma / severe allergic asthma / severe life-threatening asthma / mild-to-moderate disease / severe persistent allergic asthma / severe disease / diagnosed asthma / permanent asthma / hymenoptera venom allergy / moderate-to-severe atopic asthma / severe-resistant asthma / severe IgE-dependent asthma / severe asthma / asthma / /
MedicalTreatment
immunotherapy / /
Organization
Department of Internal Medicine / Asthma and Allergy / NFZ Program independent committee / Piotr Kuna Department of Internal Medicine / Asthma and Allergy / Barlicki University Hospital in Lodz / Norbert Barlicki Memorial University Hospital / Medical University of Lodz / European Union / Polish Society of Allergology / /
Person
Luis A. Omalizumab / Piotr Kuna / Izabela Kupryś-Lipińska / Arch Med Sci / / /
Original paper Loss of asthma control after cessation of omalizumab